Related Experiment Videos
Streptozotocin treated bullfrogs fail to develop insulin deficiency
Summary
Adult bullfrogs showed mild hyperglycemia after streptozotocin injection but maintained insulin levels. Premetamorphic tadpoles were unresponsive to streptozotocin, indicating developmental differences in glucose regulation.
Area of Science:
- Comparative physiology
- Endocrinology
- Amphibian biology
Background:
- Streptozotocin is a diabetogenic agent used to induce hyperglycemia in various species.
- Understanding the effects of streptozotocin in amphibians can provide insights into vertebrate glucose regulation.
Purpose of the Study:
- To investigate the effects of streptozotocin on glucose and insulin-like immunoreactivity (ILI) in adult bullfrogs (Rana catesbeiana) and tadpoles.
- To determine if streptozotocin induces insulin deficiency or pancreatic beta islet changes in bullfrogs.
Main Methods:
- Adult and premetamorphic bullfrogs were injected with streptozotocin (200-1000 mg/kg).
- Serum glucose and serum and pancreatic ILI were measured at various time points.
- Pancreatic beta islet histology and immunocytochemistry were performed.
Main Results:
- Adult bullfrogs exhibited mild hyperglycemia post-injection but did not develop insulin deficiency.
- Hyperglycemic adult frogs showed slightly elevated serum ILI and normal pancreatic ILI and islet morphology.
- Tadpoles did not show any significant response to streptozotocin treatment.
Conclusions:
- Adult bullfrogs possess a resistance to the diabetogenic effects of streptozotocin, unlike mammals.
- Developmental stage influences the response to streptozotocin, with tadpoles being unresponsive.
- Further research is needed to elucidate the mechanisms behind streptozotocin resistance in adult amphibians.